Immunological manifestations of HIV-infected children

Annals of Tropical Paediatrics

Volumn 19, Issue 1, 1999, Pages 3-7

  Eley, B S ^b   Hughes, J ^b   Potgieter, S ^b   Keraan, M ^b   Burgess, J ^b   Hussey, G D ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; MARKER; NEOPTERIN; PROTEIN;

ALBUMIN BLOOD LEVEL; ARTICLE; CHILDHOOD DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGY; INFANT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRESCHOOL CHILD;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULINS; INFANT; LYMPHOCYTE COUNT; MALE; PROSPECTIVE STUDIES;

EID: 0033049078     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1080/02724939992572     Document Type: Article

References (20)

1. World Health Organization. Provisional WHO clinical case definition for AIDS. Weekly Epidemiol Record 1986; 61:69-73.
2. Lambert HJ, Friesen H. Clinical features of paediatric AIDS in Uganda. Ann Trop Paediatr 1989; 9:1-5.
3. UNAIDS. The Status and Trends of the Global HIV/AIDS Pandemic: Final Report of the XIth International Conference on AIDS, Vancouver, 1996, July 7-12.
4. Meyer MP, Latief Z, Haworth C, Salie S, van Dyk A. Symptomatic HIV infection in infancy-clinical and laboratory markers of infection. South Afr J Med 1997; 87:158-62.
5. Post FA, Wood R, Maartens G. CD4 and total lymphocyte counts as predictors of HIV disease progression. Q J Med 1996; 89:505-8.
6. American Academy of Pediatrics Committee on Paediatric AIDS. Evaluation and medical treatment of the HIV-exposed infant. Pediatrics 1997; 99:909-17.
7. Centers for Disease Control and Prevention, Division of HIV/AIDS. Revised classification system for human immunodeficiency virus infection in children under 13 years of age. MMWR 1994; 43(No. RR-12):1-10.
8. Goddard EA, Malan EH, Beatty DW. IgG subclass values from normal children in Cape Town. Scand J Immunol 1992; 36(Suppl 11):210-14.
9. Yanase Y, Tango T, Okumura K, Tada T, Kawasaki T. Lymphocyte subsets identified by monoclonal antibodies in healthy children. Pediatr Res 1986; 20:1147-51.
10. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993; 328:327-35.
11. Rabin RL, Roederer M, Maldonado Y, Petru A, Herzenberg LA, Herzenberg LA. Altered representation of naive and memory CD8 T cell subsets in HIV-infectcd children. J Clin Invest 1995; 95:2054-60.
12. Tudor-Williams G, Pizzo PA. Paediatric human immunodeficiency virus infection. In: Stiehm ER, ed. Immunologic Disorders in Infants and Children, 4th edn. New York: WB Saunders, 1996; 510-52.
13. Lane HC, Fauci AS. Immunologic abnormalities in the acquired immunodeficiency syndrome. Ann Rev Immunol 1985; 3:477-500.
14. Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA 1984; 251:1447-9.
15. Roilides E, Black C, Reimer C, Rubin M, Venzon D, Pizzo PA. Serum immunoglobulin G subclasses in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J 1991; 10:134-9.
16. Mofenson LM, Moye J. Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection. Pediatr Res 1993; 33(Suppl):S80-7.
17. Kacani L, Stoiber H, Dierich MP. Role of IL-15 in HIV-1-associated hypergammaglobulinaemia. Clin Exp Immunol 1997; 108:14-18.
18. Jansson M, Wahren B, Scarlatti G, et al. Patterns of immunoglobulin G subclass reactivity to HIV-1 envelope peptides in children born to HIV-1 infected mothers. AIDS 1992; 6:365-71.
19. Landesman SH, Burns D. Quantifying HIV. JAMA 1996; 275:640-1.
20. BHIVA Guidelines Co-ordinating Committee. Consensus statement: British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1997; 349:1086-92.